Researchers have long viewed autoimmune disease and cancer as two sides of the same coin. An immune response against self-antigens results in autoimmune disease. In contrast, a lack of response to malignant cells allows cancer to develop. Studying autoimmune diseases, researchers believe, can lead to breakthroughs in the development of drugs that treat cancer.